(Q44756641)

English

Randomized, double-blind placebo- and tolterodine-controlled trial of the once-daily antimuscarinic agent solifenacin in patients with symptomatic overactive bladder

scientific article published in February 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Randomized, double-blind placebo- and tolterodine-controlled trial of the once-daily antimuscarinic agent solifenacin in patients with symptomatic overactive bladder (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

0 references

1 reference

based on heuristic

inferred from title

Christopher R Chapple

1

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

author name string

T Rechberger

2

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

S Al-Shukri

3

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

P Meffan

4

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

K Everaert

5

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

M Huang

6

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

A Ridder

7

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

YM-905 Study Group

8

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 February 2004

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

BJU International

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

93

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

303-310

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2004.04606.X

21 January 2018

How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2004.04606.X

21 January 2018

The patient with an overactive bladder--symptoms and quality-of-life issues

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2004.04606.X

21 January 2018

Denervation techniques

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2004.04606.X

21 January 2018

Muscarinic receptor antagonists in the treatment of overactive bladder

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2004.04606.X

21 January 2018

M(3) receptor antagonism by the novel antimuscarinic agent solifenacin in the urinary bladder and salivary gland

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2004.04606.X

21 January 2018

Effectiveness of anticholinergic drugs compared with placebo in the treatment of overactive bladder: systematic review

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2004.04606.X

21 January 2018

Voiding urgency and detrusor contractility in women with overactive bladders.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2004.04606.X

21 January 2018

Identifiers

10.1111/J.1464-410X.2004.04606.X

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44756641&oldid=2037555763"